Leerink Partners Starts Neurocrine Bio. (NBIX) at Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 145.58 +0.05 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.53 | 52 Week High | $58.46 | |||
| Open | $146.57 | 52 Week Low | $31.25 | |||
| Day High | $147.17 | P/E | N/A | |||
| Day Low | $145.37 | EPS | $-0.69 | |||
| Volume | 342,173 | |||||
